Contact us Demo our platform

Vaccenic Acid

Vaccenic Acid Molecule

Linear Formula

C18H34O2

Synonyms

(11E)-Octadecenoic acid, trans-Vaccenic acid, Vaccenate 

Share this metabolite

Vaccenic acid is a trans fatty acid derived from dairy fat and can be consumed from dairy products such as cow’s milk, butter, and yogurt1. It is a major trans fat found in ruminant fats and belongs to a class of long-chain fatty acids. Vaccenic acid is a positional and geometric isomer of oleic acid, one of the dominant fatty acids found in animal and vegetable oils 2. The primary source of dietary vaccenic acids is from biohydrogenation of linoleic acid, one of the most highly consumed polyunsaturated fatty acids in human diets.

Conjugated linoleic acid (CLA), another trans fatty acid, is formed in the synthesis pathway for vaccenic acid and acts as its primary dietary precursor. The cis isomer of vaccenic acid, cis vaccenic acid, can be formed by elongation of palmitoleic acid, a species of monounsaturated fatty acids. Understanding fatty acid composition in dietary sources is crucial, as it emphasizes the balance between saturated and unsaturated fatty acids, which plays a significant role in maintaining the fluidity and functionality of cell membranes.

Intake of trans fatty acids have been well studied in the context of human health. Most findings have suggested that excess intake of industrial trans fatty acids, saturated fatty acids, and a lack of unsaturated fatty acids has adverse health effects and increases the risk of metabolic syndrome (e.g. obesity and type-2 diabetes), cardiovascular disease, and cancer. However, emerging research has provided evidence for human health benefits, particularly in mitigating the negative effects on metabolism, from consuming naturally occurring trans fatty acids, including vaccenic acid.

Vaccenic Acid’s Fatty Acid Composition and Metabolic Health

Consumption of industrial trans fatty acids has been long associated with increased risk of obesity and type 2 diabetes3. Dietary consumption of these fats are linked to severe health concerns, including negative impacts on lipid metabolism, heightened inflammatory parameters, and diminished insulin sensitivity. In contrast, recent research has demonstrated that intake of naturally occurring trans fatty acids from beef, milk, and yogurt impart health benefits by ameliorating the many of the outcomes of metabolic disorders and altering free fatty acids.

For example, supplementation with vaccenic acid in obese rats significantly reduces adipocyte size4 and human studies have shown that vaccenic acid rich diets lowers cholesterol5. To understand the mechanisms that underlie the beneficial effects of vaccenic acid, one report demonstrated that vaccenic acid supplementation improves obesogenic outcomes by normalizing proinflammatory immune responses in a rat model of metabolic syndrome6.

While some studies have reported no effects on insulin signaling in obese rats4, others have demonstrated that vaccenic acid improves insulin sensitivity and decreases insulin resistance. Notably, dietary vaccenic acid significantly increased glucose turnover and increased β-cell proliferation in rats with type-2 diabetes7. In the same study, vaccenic acid application on human islets increased mRNA expression of GPR40 and REG-1ɑ, which are components of critical signaling pathways that mediate insulin secretion.

Vaccenic Acid as Trans Fats and Cardiovascular Disease

Cardiovascular disease (CVD) is one of the deleterious outcomes of metabolic disorders, and risk increases with excess intake of industrial trans fatty acids. However, the effects of vaccenic acid on cardiovascular health are mixed, ranging from neutral to beneficial.

In a report examining the effects of trans fatty acids on blood lipids, researchers found that high dietary intake of a vaccenic acid-rich butter raises plasma LDL-cholesterol concentrations and increases CVD risk. Interestingly, moderate intake showed neutral effects on CVD risk factors8. However, others have pointed to the beneficial effects of vaccenic acid on metabolic parameters (as described above) as reducing the risk of developing CVD. For example, in hypertensive rats, consumption of vaccenic acid and CLA exerted beneficial effects on cardiovascular risk biomarkers, including insulin reduction, increase of adiponectin, and improving blood pressure9. Research determining whether the consumption of vaccenic acid produces similar adverse effects on cardiovascular health as other industrial trans fats is ongoing. Regardless, these data taken together highlight the importance of moderating dietary intake of trans fatty acids and dairy consumption.

Vaccenic Acid and Oncology

Alterations in lipid metabolism have been identified as a significant risk factor for the development of numerous cancers. While intake of fats generally increases cancer risk, recent studies have highlighted the importance of elucidating the composition of dietary fats to assess cancer risk. Notably, vaccenic acid and other trans fatty acids have emerged as having treatment potential for several cancers including prostate cancer, breast cancer10 and colon cancer. 

For instance, in vitro studies using human colon adenocarcinoma cells showed that supplementation with milk lipids containing CLA and vaccenic acid altered lipid composition and inhibited cell growth11. Other reports have found that vaccenic acid application in cancer cells reprograms signaling cascades that mediate anti-tumor immunity12. 

Research on Vaccenic Acid

As of March 2024, there are 899 citations for vaccenic acid in research publications (excluding books and documents) on PubMed. The growing number of publications linking this metabolite to a broad range of physiological functions suggests that any research program seeking to better understand metabolic, cardiovascular, and oncological health may benefit from quantitative analysis of vaccenic acid. Considering the importance of vaccenic acid in biological functions, preclinical research may also benefit from vaccenic acid quantification to further the understanding of biomarkers, diagnosis, and disease monitoring.

References

  1. Lock AL and Bauman, DE. Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids 2004;(39):1197-1206.
  2. Huth PJ, Fulgoni VL 3rd, and Larson BT. A systematic review of high-oleic vegetable oil substitutions for other fats and oils on cardiovascular disease risk factors: implications for novel high-oleic soybean oils. Adv Nutr 2015;(6):674-693.
  3. van Dam RM, Willett WC, Rimm EB, et al. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002;(25):417-424.
  4. Mohankumar SK, Hanke D, Siemens L, et al. Dietary supplementation of trans-11-vaccenic acid reduces adipocyte size but neither aggravates nor attenuates obesity-mediated metabolic abnormalities in fa/fa Zucker rats. Br J Nutr 2013;(109):1628-1636.
  5. Tholstrup T, Raff M, Basu S, et al. Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr 2006;(83):237-243.
  6. Blewett HJ, Gerdung CA, Ruth MR, et al. Vaccenic acid favourably alters immune function in obese JCR:LA-cp rats. Br J Nutr 2009;(102):526-536.
  7. Wang X, Gupta J, Kerslake M, et al. Trans-11 vaccenic acid improves insulin secretion in models of type 2 diabetes in vivo and in vitro. Mol Nutr Food Res 2016;(60):846-857.
  8. Motard-Belanger A, Charest A, Grenier G, et al. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 2008;(87):593-599.
  9. Herrera-Meza MS, Mendoza-Lopez MR, Garcia-Barradas O, et al. Dietary anhydrous milk fat naturally enriched with conjugated linoleic acid and vaccenic acid modify cardiovascular risk biomarkers in spontaneously hypertensive rats. Int J Food Sci Nutr 2013;(64):575-586.
  10. Ip C, Scimeca JA, and Thompson HJ. Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer 1994;(74):1050-1054.
  11. Degen C, Lochner A, Keller S, et al. Influence of in vitro supplementation with lipids from conventional and Alpine milk on fatty acid distribution and cell growth of HT-29 cells. Lipids Health Dis 2011;(10):131.
  12. Fan H, Xia S, Xiang J, et al. Trans-vaccenic acid reprograms CD8(+) T cells and anti-tumour immunity. Nature 2023;(623):1034-1043.
✕

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.